VenMark

What VenMark does

VenMark, legally constituted as Ventas Negocios y Marketing S.A.S., is a privately held Colombian pharmaceutical consultancy founded in 2014 and headquartered in Bogotá. The firm serves pharmaceutical laboratories in Colombia that want to expand their therapeutic portfolios, offering four core service pillars: Portfolio Complement (gap analysis, molecule and generic sourcing, and negotiation with global manufacturers), Licenses & Agreements (structuring brand licensing and exclusive regional distribution deals adapted to Colombian regulation), Development & Manufacturing (coordination of galenic development, formulation, and toll manufacturing with nationally and globally certified partners), and Regulatory Consulting (end-to-end management of INVIMA sanitary registration processes, from strategy through response to observations). In addition, VenMark holds or brokers existing sanitary registrations for medical devices and medications that are available for transfer to importers and commercializers in Colombia.

The company is not a technology product firm; the source material explicitly states there is no proprietary technology platform. The offering is a human-driven consultancy with a documented four-step methodology (Diagnóstico, Búsqueda, Propuesta, Implementación) and a curated partner network of FDA- and EMA-certified manufacturers. There are no patents, no software products, no APIs, and no AI capabilities described. The firm is small (1–10 employees) with no disclosed management team, no funding rounds, no investors, and no parent company.

VenMark's business model is consultative and project-based. Revenue is generated through five streams: portfolio complement services, licensing and agreement facilitation, development and manufacturing coordination, regulatory consulting, and transaction fees for health registration transfers. Pricing is quote-based and not publicly disclosed, with proposals tailored to each client after an initial portfolio diagnosis. The go-to-market is sales-led and direct, relying on a professional website and WhatsApp-based outreach to enterprise pharmaceutical buyers rather than broad digital marketing campaigns. No customer concentration data, revenue figures, awards, or partnership announcements are publicly available.

Name

VenMark

Legal name

Ventas Negocios y Marketing SA.S

Website

https://venmark.com.co

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

VenMark is a Colombian pharmaceutical consultancy helping laboratories expand their therapeutic portfolios through partner sourcing, INVIMA regulatory management, license structuring, and development/manufacturing coordination with FDA/EMA certified manufacturers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting

NAICS

Other Scientific and Technical Consulting Services (541690), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical consulting
• Regulatory affairs services
• Pharmaceutical licensing
• Portfolio management
• Medical device registration

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Portfolio Complement Services: Identifying and managing products to expand therapeutic lines adapted to Colombian and international market needs. Revenue derived from service fees for gap analysis, molecule sourcing, and generic product identification.
2. Licensing & Agreements: Structuring license agreements for exclusive distribution between laboratories, adapted to Colombian regulations. Revenue from facilitation and negotiation services for brand license agreements and exclusive regional distribution arrangements.
3. Development & Manufacturing Coordination: Coordinating pharmaceutical development and manufacturing of molecules and medical devices with certified manufacturers. Revenue from project management and coordination services including co-development and toll manufacturing arrangements.
4. Regulatory Consulting: Integral management of regulatory processes before INVIMA, from initial strategy to final health registration approval. Includes health registration strategy and response to INVIMA observations.
5. Health Registration Transfers: The company facilitates the transfer of existing health registrations (medical devices, medications) for import and commercialization in Colombia. Current available registrations include intermittent pneumatic compression devices and rare disease treatments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

VenMark is a B2B pharmaceutical consulting firm that helps Colombian laboratories expand their therapeutic portfolios through portfolio gap analysis, sourcing of molecules and generics, structuring of licensing and exclusive distribution agreements, coordination of pharmaceutical development and manufacturing with FDA/EMA-certified partners, and full management of INVIMA sanitary registration processes. It also brokers the transfer of existing sanitary registrations for selected medical devices and medications into Colombia.

Product overview

VenMark offers a unified service platform for portfolio complement solutions in the pharmaceutical industry and health sector in Colombia. The core offering integrates four main service areas: Portfolio Complement (identifying products to expand therapeutic lines), Licenses and Agreements (structuring exclusive distribution licensing), Development and Manufacturing (coordinating pharmaceutical and medical device manufacturing with certified manufacturers), and Regulatory Consulting (managing INVIMA registration processes). Additionally, the company offers products with existing sanitary registrations available for transfer, including medical devices (Intermittent Pneumatic Compression, Ankle-Brachial Index System) and medications (Rare High-Cost Disease treatments, Chronic Treatments).

Differentiator

Problem solved

Functional benefit

Products and services

• Complemento de Portafolio (Portfolio Complement) Service that identifies and manages products to expand therapeutic lines adapted to Colombian and international market needs. Includes therapeutic gap analysis, molecule and generic sourcing, and negotiation with global manufacturers. Targeted at pharmaceutical laboratories in Colombia seeking to complement their portfolios.
• Licencias y Acuerdos (Licenses and Agreements) Structures licensing agreements for exclusive distribution between laboratories, adapted to Colombian regulations. Includes brand license agreements and exclusive regional distribution. Targeted at pharmaceutical laboratories seeking to enter or expand in Colombia via licensing.
• Desarrollo y Fabricación (Development and Manufacturing) Coordinates pharmaceutical development and manufacturing of molecules and medical devices with nationally and globally certified manufacturers. Includes galenic development, formulation, quality control and validation, co-development, and toll manufacturing. Targeted at pharmaceutical laboratories seeking manufacturing partners.
• Consultoría Regulatoria (Regulatory Consulting) Manages integral regulatory processes before INVIMA, from initial strategy to final sanitary registration approval. Includes health registration strategy, response to INVIMA observations, and technical consulting. Targeted at pharmaceutical laboratories introducing products into Colombia.
• Compresión Neumática Intermitente (Intermittent Pneumatic Compression) Medical device for intermittent pneumatic compression for hospital and ambulatory use. Current sanitary registration available for transfer for import and commercialization in Colombia.
• Sistema de Índice Tobillo Brazo ITB (Ankle-Brachial Index System) Medical device for Ankle-Brachial Index (ABI) measurement, for hospital and ambulatory use. Current sanitary registration available for transfer for import and commercialization in Colombia.
• Enfermedad Rara Alto Costo (Rare High-Cost Disease Medication) Medication indicated for rare high-cost diseases. Current sanitary registration available for transfer for import and commercialization in Colombia.
• Tratamiento Crónico (Chronic Treatment Medication) Medication indicated for chronic treatments. Current sanitary registration available for transfer for import and commercialization in Colombia.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• ICON plc: Global CRO offering regulatory affairs, clinical development, and consulting services to pharmaceutical and biotech clients. Comparable on regulatory consulting for pharma product registration, though it is a much broader CRO with clinical and lab capabilities VenMark does not have.
• Charles River Laboratories: Global CRO with a regulatory consulting arm (formerly CDMO + regulatory services) serving pharma and biotech. Comparable to VenMark on the regulatory affairs and manufacturing-coordination side, although Charles River operates at much greater scale and adds discovery/manufacturing.
• IQVIA: Large global life sciences services firm providing regulatory consulting, market access, and commercialization support across LATAM and globally. Overlaps with VenMark on regulatory affairs for pharma labs in Colombia but operates at vastly larger scale and broader portfolio.

Direct peers

• Certara: Scientific and regulatory consulting firm providing regulatory strategy, CMC documentation, and product development support to pharma companies. Strongly comparable to VenMark on the CMC/regulatory documentation and submission-side focus, though at global scale with proprietary technology.
• ProPharma Group: Global pharmaceutical regulatory, compliance, and consulting firm offering regulatory affairs support, M&A due diligence, and product lifecycle consulting. Directly comparable to VenMark in providing specialized regulatory and portfolio advisory services to pharmaceutical manufacturers and labs.
• PharmaLex: Regulatory affairs and pharmacovigilance consulting firm (now part of Cencora) supporting pharma clients across development, registration, and market access. Comparable to VenMark on specialized regulatory consulting and licensing/registration transfer work for pharmaceutical products.

Emerging players

• Veristat: Mid-size clinical and regulatory consulting firm focused on product development and regulatory submission support for pharma/biotech. Comparable to VenMark on the regulatory consulting and product registration support side, positioned as a smaller-scale, more specialized player than the global CROs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pharmaceutical-training-center-sas

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VenMark